Certain statements in this website may constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Such forward-looking statements reflect management’s current views with respect to future events and may address current expectations regarding results, performance, regulatory approvals, regulatory clearance, product introductions, entry into new geographic regions, technology initiatives or achievements of Intelligent Bio Solutions Inc. and its affiliates (“IBS”). Statements that are not historical fact are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language, such as the words “plan,” “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “may,” “will,” “would,” “could,” “should,” “seeks,” “forecast” or “scheduled to,” or other similar words, or the negative of these terms or other variations of these terms or comparable language, or by discussion of strategy or intentions.

Factors that could cause actual results to differ materially from our forward-looking statements include the following:

• our ability to successfully integrate acquisitions;
• our ability to successfully develop and commercialize our drug and diagnostic tests;
• our ability to realize commercial benefit from our partnerships and collaborations;
• our ability to secure regulatory approvals or clearance;
• compliance with obligations under intellectual property licenses with third parties;
• our ability to establish or maintain collaborations, licensing or other arrangements;
• our ability and third parties’ abilities to protect intellectual property rights;
• our ability to adequately support future growth; and
• our ability to attract and retain key personnel to manage our business effectively.